Klinge Pharma GmbH is a pharmaceutical company primarily operating in Germany, headquartered in Holzkirchen. Its product portfolio comprises medicinal products, medical cosmetics and nutritional supplements with a focus on gastroenterology, dermatology, venous and urinary tract diseases as well as probiotics. Reported brands include e.g. Vomex®, Kohle‑Compretten®, Physiogel®, Calcipotriol comp Klinge, Adapaben®, Ketoconazol Klinge®, Venostasin®, Utipro®, SymbioFlor® 1/2 and SymbioLact®, and from February 2024 the company also distributes SymbioPharm products. Distribution is predominantly through pharmacies and the clinical sector; 94% of 2024 revenues were generated domestically.
Der Vertrieb von Arzneimitteln, Medizinprodukten, Nahrungsergänzungsmitteln sowie weiteren Gesundheitsprodukten.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 232592 (as of 10 October 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 232592 (as of 10 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 232592 (as of 10 October 2026)
Sign in to view detailed salary and cost trends.
